 Leishmania
"Leishmania" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.
| Descriptor ID |
D007891
|
| MeSH Number(s) |
B01.268.475.868.488
|
| Concept/Terms |
Leishmania viannia- Leishmania viannia
- Leishmania viannias
- viannia, Leishmania
- viannias, Leishmania
- Leishmania (Viannia)
- Leishmanias (Viannia)
Leishmania (Leishmania)- Leishmania (Leishmania)
- Leishmanias (Leishmania)
- Leishmania leishmania
- Leishmania leishmanias
- leishmania, Leishmania
- leishmanias, Leishmania
|
Below are MeSH descriptors whose meaning is more general than "Leishmania".
Below are MeSH descriptors whose meaning is more specific than "Leishmania".
This graph shows the total number of publications written about "Leishmania" by people in this website by year, and whether "Leishmania" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 1 | 0 | 1 | | 1989 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2013 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leishmania" by people in Profiles.
-
Martin CJ, Peters KN, Behar SM. Macrophages clean up: efferocytosis and microbial control. Curr Opin Microbiol. 2014 Feb; 17:17-23.
-
Costa MM, Andrade HM, Bartholomeu DC, Freitas LM, Pires SF, Chapeaurouge AD, Perales J, Ferreira AT, Giusta MS, Melo MN, Gazzinelli RT. Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine. J Proteome Res. 2011 May 6; 10(5):2172-84.
-
Morita YS, Yamaryo-Botte Y, Miyanagi K, Callaghan JM, Patterson JH, Crellin PK, Coppel RL, Billman-Jacobe H, Kinoshita T, McConville MJ. Stress-induced synthesis of phosphatidylinositol 3-phosphate in mycobacteria. J Biol Chem. 2010 May 28; 285(22):16643-50.
-
Sabri A, Khatib L, Kanj-Sharara S, Husseini ST, Nuwayri-Salti N, Semaan R, Rameh C. Leishmaniasis of the auricle mimicking carcinoma. Am J Otolaryngol. 2009 Jul-Aug; 30(4):285-7.
-
Vale AM, Fujiwara RT, da Silva Neto AF, Miret JA, Alvarez DC, da Silva JC, Campos-Neto A, Reed S, Mayrink W, Nascimento E. Identification of highly specific and cross-reactive antigens of Leishmania species by antibodies from Leishmania (Leishmania) chagasi naturally infected dogs. Zoonoses Public Health. 2009 Feb; 56(1):41-8.
-
Gollob KJ, Antonelli LR, Faria DR, Keesen TS, Dutra WO. Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol. 2008 Oct; 8(10):1338-43.
-
Badaro R, Lobo I, Munos A, Netto EM, Modabber F, Campos-Neto A, Coler RN, Reed SG. Immunotherapy for drug-refractory mucosal leishmaniasis. J Infect Dis. 2006 Oct 15; 194(8):1151-9.
-
Gollob KJ, Antonelli LR, Dutra WO. Insights into CD4+ memory T cells following Leishmania infection. Trends Parasitol. 2005 Aug; 21(8):347-50.
-
Campos-Neto A. What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? Braz J Med Biol Res. 2005 Jul; 38(7):979-84.
-
Reed SG, Coler RN, Campos-Neto A. Development of a leishmaniasis vaccine: the importance of MPL. Expert Rev Vaccines. 2003 Apr; 2(2):239-52.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|